These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26852756)

  • 1. Does the urea breath test predict eradication of Helicobacter pylori infection?
    Unler GK; Ozgur GT; Gokturk HS; Durukan E; Erhamamci S
    Acta Gastroenterol Belg; 2016 Mar; 79(1):3-7. PubMed ID: 26852756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication Rate of
    Liu RP; Romero R; Sarosiek J; Dodoo C; Dwivedi AK; Zuckerman MJ
    South Med J; 2018 Jan; 111(1):51-55. PubMed ID: 29298370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
    Onal IK; Gokcan H; Benzer E; Bilir G; Oztas E
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):642-6. PubMed ID: 23796974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children.
    Tümgör G; Baran M; Çakır M; Yüksekkaya HA; Aydoğdu S
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():99-103. PubMed ID: 25910378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study.
    Ergül B; Doğan Z; Sarikaya M; Filik L
    Helicobacter; 2013 Dec; 18(6):454-8. PubMed ID: 24011287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
    Gisbert JP; Bermejo F; Castro-Fernández M; Pérez-Aisa A; Fernández-Bermejo M; Tomas A; Barrio J; Bory F; Almela P; Sánchez-Pobre P; Cosme A; Ortiz V; Niño P; Khorrami S; Benito LM; Carneros JA; Lamas E; Modolell I; Franco A; Ortuño J; Rodrigo L; García-Durán F; O'Callaghan E; Ponce J; Valer MP; Calvet X;
    Am J Gastroenterol; 2008 Jan; 103(1):71-6. PubMed ID: 17764498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.
    Aguemon B; Struelens M; Devière J; Denis O; Golstein P; Salmon I; Nagy N
    Acta Gastroenterol Belg; 2005; 68(3):287-93. PubMed ID: 16268413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.
    Perri F; Clemente R; Festa V; Quitadamo M; Conoscitore P; Niro G; Ghoos Y; Rutgeerts P; Andriulli A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):146-50. PubMed ID: 9675647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.
    Gisbert JP; Romano M; Molina-Infante J; Lucendo AJ; Medina E; Modolell I; Rodríguez-Tellez M; Gomez B; Barrio J; Perona M; Ortuño J; Ariño I; Domínguez-Muñoz JE; Perez-Aisa Á; Bermejo F; Domínguez JL; Almela P; Gomez-Camarero J; Millastre J; Martin-Noguerol E; Gravina AG; Martorano M; Miranda A; Federico A; Fernandez-Bermejo M; Angueira T; Ferrer-Barcelo L; Fernández N; Marín AC; McNicholl AG
    Dig Liver Dis; 2015 Feb; 47(2):108-13. PubMed ID: 25454706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
    Dib J; Alvarez B; Mendez L; Cruz ME
    Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
    Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
    Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
    Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.
    Buzás GM; Széles I
    J Gastroenterol; 2008; 43(2):108-14. PubMed ID: 18306984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.